Your browser doesn't support javascript.
loading
Validation of the society of thoracic surgeons predicted risk of mortality score for long-term survival after cardiac surgery in Israel.
Ben-David, Eyal I; Blumenfeld, Orit; Shapira-Daniels, Ayelet; Shapira, Oz M.
Afiliação
  • Ben-David EI; Department of Cardiothoracic Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel. eyalbendavid@hotmail.com.
  • Blumenfeld O; St George's Hospital Medical School, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. eyalbendavid@hotmail.com.
  • Shapira-Daniels A; The Israel Center for Disease Control, Division of Medical Technologies and Research, Ministry of Health, Ramat Gan, Israel.
  • Shapira OM; Department of Cardiothoracic Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
J Cardiothorac Surg ; 17(1): 68, 2022 Apr 05.
Article em En | MEDLINE | ID: mdl-35382843
ABSTRACT

BACKGROUND:

Long-term survival is an important metric in assessing procedural value. We previously confirmed that the Society of Thoracic Surgeons predicted risk of mortality score (PROM) accurately predicts 30-day mortality in Israeli patients. The present study investigated the ability of the PROM to reliably predict long-term survival.

METHODS:

Data on 1279 patients undergoing cardiac surgery were prospectively entered into our database and used to calculate PROM. Long-term mortality was obtained from the Israeli Social Security Database. Patients were stratified into five cohorts according to PROM (A 0-0.99%, B 1.0-1.99%, C 2.0-2.99%, D 3.0-4.99% and E ≥ 5.0%). Kaplan-Meier estimates of survival were calculated for each cohort and compared by Wilcoxon signed-rank test. We used C-statistics to assess model discrimination. Cox regression analysis was performed to identify predictors of long-term survival.

RESULTS:

Follow-up was achieved for 1256 (98%) patients over a mean period of 62 ± 28 months (median 64, range 0-107). Mean survival of the entire cohort was 95 ± 1 (95% CI 93-96) months. Higher PROM was associated with reduced survival A-104 ± 1 (103-105) months, B-96 ± 2 (93-99) months, C-93 ± 3 (88-98) months, D-89 ± 3 (84-94) months, E-74 ± 3 (68-80) months (p < 0.0001). The Area Under the Curve was 0.76 ± 0.02 indicating excellent model discrimination. Independent predictors of long-term mortality included advanced age, lower ejection fraction, reoperation, diabetes mellitus, dialysis and PROM.

CONCLUSIONS:

The PROM was a reliable predictor of long-term survival in Israeli patients undergoing cardiac surgery. The PROM might be a useful metric for assessing procedural value and surgical decision-making.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cirurgia Torácica / Cirurgiões / Procedimentos Cirúrgicos Cardíacos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cirurgia Torácica / Cirurgiões / Procedimentos Cirúrgicos Cardíacos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article